CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Teladoc Health, Inc. - TDOC CFD

18.91
4.59%
Market Trading Hours* (UTC) Opens on Monday at 14:30

Mon - Fri: 14:30 - 21:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.13
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026235 %
Charges from full value of position ($-4.98)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026235%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.004012 %
Charges from full value of position ($0.76)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.004012%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Teladoc Health Inc ESG Risk Ratings

High Medium Low Negligible

‘D’ score indicates poor relative ESG performance and insufficient degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 18.08
Open* 17.94
1-Year Change* -36.83%
Day's Range* 17.94 - 18.94
52 wk Range 15.02-34.36
Average Volume (10 days) 4.11M
Average Volume (3 months) 100.18M
Market Cap 2.80B
P/E Ratio -100.00K
Shares Outstanding 165.56M
Revenue 2.58B
EPS -24.66
Dividend (Yield %) N/A
Beta 1.09
Next Earnings Date Feb 20, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Nov 30, 2023 18.08 -0.31 -1.69% 18.39 18.54 17.87
Nov 29, 2023 18.32 0.03 0.16% 18.29 19.25 18.26
Nov 28, 2023 18.03 1.02 6.00% 17.01 18.16 16.89
Nov 27, 2023 17.15 0.00 0.00% 17.15 17.21 16.86
Nov 24, 2023 17.29 0.17 0.99% 17.12 17.40 17.05
Nov 22, 2023 16.98 -0.08 -0.47% 17.06 17.29 16.86
Nov 21, 2023 16.86 -0.31 -1.81% 17.17 17.20 16.78
Nov 20, 2023 17.41 0.32 1.87% 17.09 17.66 16.90
Nov 17, 2023 17.11 0.15 0.88% 16.96 17.12 16.74
Nov 16, 2023 16.87 -0.34 -1.98% 17.21 17.37 16.59
Nov 15, 2023 17.47 0.42 2.46% 17.05 17.75 17.05
Nov 14, 2023 16.99 0.78 4.81% 16.21 17.12 16.21
Nov 13, 2023 15.58 -0.25 -1.58% 15.83 16.00 15.57
Nov 10, 2023 15.88 0.41 2.65% 15.47 15.93 15.42
Nov 9, 2023 15.60 -0.61 -3.76% 16.21 16.43 15.53
Nov 8, 2023 16.13 -0.43 -2.60% 16.56 16.78 16.13
Nov 7, 2023 16.89 0.13 0.78% 16.76 17.04 16.43
Nov 6, 2023 16.74 -0.62 -3.57% 17.36 17.41 16.41
Nov 3, 2023 17.33 0.11 0.64% 17.22 17.91 17.08
Nov 2, 2023 16.87 -0.19 -1.11% 17.06 17.17 16.51

Teladoc Health, Inc. Events

Time (UTC) Country Event
Tuesday, February 20, 2024

Time (UTC)

10:59

Country

US

Event

Q4 2023 Teladoc Health Inc Earnings Release
Q4 2023 Teladoc Health Inc Earnings Release

Forecast

-

Previous

-
Wednesday, April 24, 2024

Time (UTC)

10:59

Country

US

Event

Q1 2024 Teladoc Health Inc Earnings Release
Q1 2024 Teladoc Health Inc Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 2406.84 2032.71 1093.96 553.307 417.907
Revenue 2406.84 2032.71 1093.96 553.307 417.907
Cost of Revenue, Total 743.987 650.258 390.829 184.465 128.735
Gross Profit 1662.85 1382.45 703.133 368.842 289.172
Total Operating Expense 16060.1 2342.09 1609.46 633.749 488.761
Selling/General/Admin. Expenses, Total 1300.56 1105.31 886.882 339.068 265.16
Research & Development 333.629 311.884 164.941 64.644 54.373
Depreciation / Amortization 256.027 204.239 69.495 38.952 35.602
Unusual Expense (Income) 13425.8 70.391 97.313 6.62 4.891
Operating Income -13653.2 -309.379 -515.498 -80.442 -70.854
Interest Income (Expense), Net Non-Operating -9.27 -80.365 -60.495 -29.013 -26.112
Net Income Before Taxes -13663.3 -384.656 -575.993 -109.455 -96.966
Net Income After Taxes -13659.5 -428.793 -485.136 -98.864 -97.084
Net Income Before Extra. Items -13659.5 -428.793 -485.136 -98.864 -97.084
Net Income -13659.5 -428.793 -485.136 -98.864 -97.084
Income Available to Common Excl. Extra. Items -13659.5 -428.793 -485.136 -98.864 -97.084
Income Available to Common Incl. Extra. Items -13659.5 -428.793 -485.136 -98.864 -97.084
Diluted Net Income -13659.5 -428.793 -485.136 -98.864 -97.084
Diluted Weighted Average Shares 161.457 156.939 90.5092 71.8445 65.8449
Diluted EPS Excluding Extraordinary Items -84.6016 -2.73223 -5.36007 -1.37608 -1.47443
Diluted Normalized EPS -30.5513 -2.44069 -4.66121 -1.31619 -1.42615
Total Extraordinary Items
Other, Net -0.859 5.088
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total revenue 660.238 652.406 629.244 637.709 611.402
Revenue 660.238 652.406 629.244 637.709 611.402
Cost of Revenue, Total 185.96 190.54 190.107 188.873 185.619
Gross Profit 474.278 461.866 439.137 448.836 425.783
Total Operating Expense 724.963 724.051 706.346 4453.26 683.132
Selling/General/Admin. Expenses, Total 354.177 358.127 345.425 324.243 346.096
Research & Development 84.289 87.309 86.985 77.576 87.815
Depreciation / Amortization 94.302 75.465 69.783 75.715 62.008
Unusual Expense (Income) 6.235 12.61 14.046 3786.85 1.594
Operating Income -64.725 -71.645 -77.102 -3815.55 -71.73
Interest Income (Expense), Net Non-Operating 6.96 5.723 3.648 1.893 -1.346
Other, Net -1.792 -0.207 4.907 1.748 -1.571
Net Income Before Taxes -59.557 -66.129 -68.547 -3811.91 -74.647
Net Income After Taxes -57.073 -65.177 -69.228 -3810.07 -73.476
Net Income Before Extra. Items -57.073 -65.177 -69.228 -3810.07 -73.476
Net Income -57.073 -65.177 -69.228 -3810.07 -73.476
Income Available to Common Excl. Extra. Items -57.073 -65.177 -69.228 -3810.07 -73.476
Income Available to Common Incl. Extra. Items -57.073 -65.177 -69.228 -3810.07 -73.476
Diluted Net Income -57.073 -65.177 -69.228 -3810.07 -73.476
Diluted Weighted Average Shares 165.119 164.171 162.923 162.177 161.728
Diluted EPS Excluding Extraordinary Items -0.34565 -0.39701 -0.42491 -23.4932 -0.45432
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.3211 -0.34708 -0.36887 -8.31568 -0.44791
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 1315.39 1225.44 1059.61 588.002 532.736
Cash and Short Term Investments 918.182 896.017 786.569 517.064 478.534
Cash & Equivalents 918.182 893.48 733.324 514.353 423.989
Short Term Investments 0 2.537 53.245 2.711 54.545
Total Receivables, Net 235.645 168.956 169.281 56.948 43.571
Accounts Receivable - Trade, Net 210.554 168.956 169.281 56.948 43.571
Prepaid Expenses 63.159 87.387 47.259 13.99 10.631
Total Assets 4345.35 17734.6 17755.3 1602.83 1528.88
Property/Plant/Equipment, Total - Net 71.472 74.014 75.198 36.748 10.148
Property/Plant/Equipment, Total - Gross 119.184 108.144 97.163 52.51 22.431
Accumulated Depreciation, Total -47.712 -34.13 -21.965 -15.762 -12.283
Goodwill, Net 1073.19 14504.2 14581.3 746.079 737.197
Intangibles, Net 1836.77 1910.28 2020.86 225.453 247.394
Other Long Term Assets, Total 48.54 20.703 18.357 6.545 1.401
Total Current Liabilities 399.769 331.013 332.649 90.181 62.439
Accounts Payable 47.69 47.257 46.03 9.075 7.769
Accrued Expenses 193.44 162.009 156.066 57.785 41.212
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 11.375 13.313 56.013
Other Current Liabilities, Total 147.264 108.434 74.54 23.321 13.458
Total Liabilities 2037.61 1688.85 1871.48 588.802 515.757
Total Long Term Debt 1543.37 1234.96 1389.52 440.41 414.683
Long Term Debt 1543.37 1234.96 1389.52 440.41 414.683
Deferred Income Tax 50.939 75.777 102.103 21.678 32.444
Other Liabilities, Total 43.532 47.099 47.207 36.533 6.191
Total Equity 2307.75 16045.8 15883.8 1014.03 1013.12
Common Stock 0.163 0.16 0.15 0.073 0.07
Additional Paid-In Capital 17358.6 17473.3 16857.8 1538.72 1434.78
Retained Earnings (Accumulated Deficit) -15008.3 -1421.45 -992.661 -507.525 -408.661
Other Equity, Total -42.776 -6.285 18.518 -17.239 -13.07
Total Liabilities & Shareholders’ Equity 4345.35 17734.6 17755.3 1602.83 1528.88
Total Common Shares Outstanding 162.84 160.469 150.281 72.7619 70.5163
Total Inventory 56.342 73.079 56.498
Other Current Assets, Total 42.06
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 1387.09 1320.96 1286.71 1315.39 1287.59
Cash and Short Term Investments 1030.53 958.695 888.579 918.182 899.631
Cash & Equivalents 1030.53 958.695 888.579 918.182 899.631
Short Term Investments 0 0
Total Receivables, Net 218.741 227.444 241.08 210.554 201.701
Accounts Receivable - Trade, Net 205.866 215.181 215.981 210.554 201.701
Total Inventory 35.916 34.054 45.801 56.342 59.344
Prepaid Expenses 62.248 62.103 77.526 130.31 126.912
Total Assets 4327.97 4316.4 4309.15 4345.35 8103.96
Property/Plant/Equipment, Total - Net 64.938 65.216 69.309 71.472 72.457
Goodwill, Net 1073.19 1073.19 1073.19 1073.19 4846
Intangibles, Net 1728.3 1784.1 1815.95 1836.77 1854.26
Other Long Term Assets, Total 74.452 72.93 63.993 48.54 43.656
Total Current Liabilities 402.64 383.394 381.344 399.769 411.401
Accounts Payable 25.998 16.071 38.625 47.69 70.783
Accrued Expenses 224.739 208.116 192.872 193.44 202.633
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 11.247 11.375 10.086
Other Current Liabilities, Total 151.903 159.207 138.6 147.264 127.899
Total Liabilities 2033.92 2021.26 2017.92 2037.61 2051.3
Total Long Term Debt 1537.83 1536.98 1544.17 1543.37 1542.3
Long Term Debt 1537.83 1536.98 1544.17 1543.37 1542.3
Deferred Income Tax 44.252 48.097 50.613 50.939 51.742
Other Liabilities, Total 49.198 52.789 41.793 43.532 45.858
Total Equity 2294.05 2295.14 2291.23 2307.75 6052.66
Common Stock 0.166 0.165 0.164 0.163 0.162
Additional Paid-In Capital 17535.2 17476.5 17409.6 17358.6 17300
Retained Earnings (Accumulated Deficit) -15199.8 -15142.7 -15077.5 -15008.3 -11198.2
Other Equity, Total -41.52 -38.78 -40.997 -42.776 -49.266
Total Liabilities & Shareholders’ Equity 4327.97 4316.4 4309.15 4345.35 8103.96
Total Common Shares Outstanding 165.557 164.877 163.919 162.84 162.196
Other Current Assets, Total 39.659 38.668 33.721
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line -13659.5 -428.793 -485.136 -98.864 -97.084
Cash From Operating Activities 189.292 193.99 -53.511 29.869 -4.86
Cash From Operating Activities 258.886 204.239 71.192 44.952 35.602
Deferred Taxes -7.84 41.8 -90.158 -10.868 -2.247
Non-Cash Items 13658.7 427.068 541.074 94.805 59.999
Cash Interest Paid 17.361 16.43 14.89 12.224 10.303
Changes in Working Capital -60.971 -50.324 -90.483 -0.156 -1.13
Cash From Investing Activities -167.743 -72.981 -590.975 25.013 -257.496
Capital Expenditures -172.764 -63.934 -26.042 -10.9 -8.407
Other Investing Cash Flow Items, Total 5.021 -9.047 -564.933 35.913 -249.089
Cash From Financing Activities 6.497 40.947 859.136 35.094 645.612
Financing Cash Flow Items -2.741 -0.73 -36.703 -1.569 1.721
Issuance (Retirement) of Stock, Net 12.385 42.591 59.036 36.663 364.729
Issuance (Retirement) of Debt, Net -3.147 -0.914 836.803 0 279.162
Foreign Exchange Effects -3.344 -1.8 4.321 0.388 -2.084
Net Change in Cash 24.702 160.156 218.971 90.364 381.172
Cash Taxes Paid 2.512 3.974 1.324 1.31 0.441
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -69.228 -13659.5 -9849.46 -9775.98 -6674.52
Cash From Operating Activities 13.156 189.292 123.743 60.722 -31.747
Cash From Operating Activities 70.464 258.886 182.497 119.79 59.703
Deferred Taxes -0.355 -7.84 -5.942 -2.528 -2.319
Non-Cash Items 55.451 13658.7 9821.4 9755.49 6669.03
Cash Taxes Paid 0.346 2.512 0.901 0.564 0.261
Cash Interest Paid 0.194 17.361 8.688 8.673 0.007
Changes in Working Capital -43.176 -60.971 -24.756 -36.048 -83.634
Cash From Investing Activities -45.624 -167.743 -113.852 -72.404 -27.567
Capital Expenditures -45.624 -172.764 -118.873 -75.668 -30.831
Other Investing Cash Flow Items, Total 0 5.021 5.021 3.264 3.264
Cash From Financing Activities 3.353 6.497 2.116 1.482 2.816
Financing Cash Flow Items 0.499 -2.741 -2.253 -2.794 -2.76
Issuance (Retirement) of Stock, Net 3.027 12.385 9.032 6.952 7.265
Issuance (Retirement) of Debt, Net -0.173 -3.147 -4.663 -2.676 -1.689
Foreign Exchange Effects -0.488 -3.344 -5.856 -2.119 -0.538
Net Change in Cash -29.603 24.702 6.151 -12.319 -57.036
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
ARK Investment Management LLC Investment Advisor 12.2688 20311873 -32228 2023-09-30 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 10.4371 17279450 1268630 2023-06-30 LOW
Nikko Asset Management Co., Ltd. Investment Advisor/Hedge Fund 4.6435 7687646 -181228 2023-09-30 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 4.4715 7402854 -669382 2023-06-30 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 3.1028 5136970 170726 2023-06-30 LOW
Renaissance Technologies LLC Hedge Fund 2.6624 4407819 1038319 2023-06-30 HIGH
Michigan Department of Treasury Pension Fund 1.9105 3163000 -670000 2023-09-30
Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 1.6921 2801351 -792468 2023-06-30 LOW
Nikko Asset Management Americas, Inc. Investment Advisor/Hedge Fund 1.6632 2753556 -27174 2022-12-31 LOW
First Trust Advisors L.P. Investment Advisor 1.4917 2469576 854434 2023-06-30 MED
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.4214 2353278 127309 2023-06-30 LOW
Federated MDTA LLC Investment Advisor/Hedge Fund 1.3566 2245905 -267620 2023-06-30 HIGH
Two Sigma Investments, LP Hedge Fund 1.3185 2182947 -3179155 2023-06-30 HIGH
Himension Capital (Singapore) Pte. Ltd Investment Advisor 1.305 2160507 -82100 2023-06-30 MED
Baillie Gifford & Co. Investment Advisor 1.0731 1776578 -3050303 2023-06-30 LOW
Balyasny Asset Management LP Hedge Fund 1.0304 1705844 1295092 2023-06-30 HIGH
BlackRock Financial Management, Inc. Investment Advisor/Hedge Fund 0.9389 1554448 -297480 2023-06-30 LOW
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 0.8845 1464347 89223 2022-12-31 LOW
Credit Suisse Funds AG Investment Advisor/Hedge Fund 0.7518 1244679 -33934 2023-06-30 LOW
AHL Partners LLP Hedge Fund 0.7042 1165901 261493 2023-06-30 HIGH

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Teladoc Health, Inc. Company profile

Teladoc Health Inc provides virtual healthcare services on a business-to-business basis in the US and internationally. According to the company, it’s the largest telehealth platform in the US.

The company looks to provide fast, remotely accessible and affordable healthcare. Teladoc connects customers with over 1,100 board-certified physicians and behavioural health professionals, delivering on-demand healthcare via the internet on video or phone.

Teladoc Health serves numerous corporations, health plans, health systems and other entities. The company generates revenue via subscriptions and per visit fees.

The company provides point-of-care devices and solutions – Viewpoint Cart, TV Pro, Xpress Cart, Vantage and Vita – to hospitals for patient care and monitoring. Teladoc Health also offers its products and services under the brands Teladoc, InTouch Health, Livongo, BetterHelp, MedecinDirect and HealthiestYou.

Jason Gorevic has been the company’s chief executive since 2009. The company was initially known as Teladoc. It was renamed Teladoc Health in August 2018. Teladoc Health was incorporated in 2002. It’s headquartered in Purchase, New York.

Industry: Telemedicine Services

2 Manhattanville Rd Ste 203
PURCHASE
NEW YORK 10577-2118
US

Income Statement

  • Annual
  • Quarterly

News

CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

12:39, 30 November 2023

Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

EZ PI expected to drop further but speed of decline

08:16, 29 November 2023

A weaker Dollar drives gold higher

Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

13:49, 28 November 2023

Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

13:20, 28 November 2023

RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

13:04, 28 November 2023

Crude prices slide on OPEC+ uncertainty

Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

12:55, 28 November 2023
GBP

UK AUTUMN BUDGET: Will Hunt cut taxes? How will GBP react this time around?

UK Chancellor Hunt will deliver the 2023 autumn statement to MPs on Wednesday 22 November.

10:48, 21 November 2023

People also watch

US100

16,001.20 Price
+0.470% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 22:00 (UTC)
Spread 7.0

Gold

2,072.25 Price
+1.760% 1D Chg, %
Long position overnight fee -0.0193%
Short position overnight fee 0.0111%
Overnight fee time 22:00 (UTC)
Spread 0.30

Oil - Crude

74.50 Price
-1.560% 1D Chg, %
Long position overnight fee -0.0136%
Short position overnight fee -0.0083%
Overnight fee time 22:00 (UTC)
Spread 0.040

XRP/USD

0.62 Price
+0.830% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 22:00 (UTC)
Spread 0.01168

Still looking for a broker you can trust?

Join the 570.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading